Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice

American Journal of Pathology

Volumn 182, Issue 4, 2013, Pages 1124-1130

  Bosmann, Markus ^a,b   Meta, Fabien ^a   Ruemmler, Robert ^a   Haggadone, Mikel D ^a   Sarma, J Vidya ^a   Zetoune, Firas S ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DEXAMETHASONE; GLUCOCORTICOID; HETERODIMER; HYDROCORTISONE; INTERLEUKIN 17; INTERLEUKIN 17AF; INTERLEUKIN 17F; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; NORADRENALIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; IMMUNOMODULATION; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEPSIS; SHAM PROCEDURE;

ADRENALECTOMY; ANIMALS; CATECHOLAMINES; ENDOTOXEMIA; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; INTERLEUKIN-17; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; SEPSIS;

EID: 84875167756     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.005     Document Type: Article

References (42)

1. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546 1554
2. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
3. D. Rittirsch, M.A. Flierl, and P.A. Ward Harmful molecular mechanisms in sepsis Nat Rev Immunol 8 2008 776 787
4. J.S. Boomer, K. To, K.C. Chang, O. Takasu, D.F. Osborne, A.H. Walton, T.L. Bricker, S.D. Jarman 2nd, D. Kreisel, A.S. Krupnick, A. Srivastava, P.E. Swanson, J.M. Green, and R.S. Hotchkiss Immunosuppression in patients who die of sepsis and multiple organ failure JAMA 306 2011 2594 2605
5. R.S. Hotchkiss, P.E. Swanson, B.D. Freeman, K.W. Tinsley, J.P. Cobb, G.M. Matuschak, T.G. Buchman, and I.E. Karl Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction Crit Care Med 27 1999 1230 1251
6. T.J. Murphy, H.M. Paterson, J.A. Mannick, and J.A. Lederer Injury, sepsis, and the regulation of Toll-like receptor responses J Leukoc Biol 75 2004 400 407
7. M. Bosmann, J.V. Sarma, G. Atefi, F.S. Zetoune, and P.A. Ward Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis FASEB J 26 2012 1640 1651
8. M.A. Flierl, D. Rittirsch, H. Gao, L.M. Hoesel, B.A. Nadeau, D.E. Day, F.S. Zetoune, J.V. Sarma, M.S. Huber-Lang, J.L. Ferrara, and P.A. Ward Adverse functions of IL-17A in experimental sepsis FASEB J 22 2008 2198 2205
9. K. Shibata, H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production J Immunol 178 2007 4466 4472
10. Z. Yao, S.L. Painter, W.C. Fanslow, D. Ulrich, B.M. Macduff, M.K. Spriggs, and R.J. Armitage Human IL-17: a novel cytokine derived from T cells J Immunol 155 1995 5483 5486
11. T. Starnes, M.J. Robertson, G. Sledge, S. Kelich, H. Nakshatri, H.E. Broxmeyer, and R. Hromas Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production J Immunol 167 2001 4137 4140
12. S.D. Hurst, T. Muchamuel, D.M. Gorman, J.M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T.T. Kung, J.K. Brieland, S.M. Zurawski, R.W. Chapman, G. Zurawski, and R.L. Coffman New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 J Immunol 169 2002 443 453
13. S.H. Chang, and C. Dong A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses Cell Res 17 2007 435 440
14. M. Bosmann, V.R. Patel, N.F. Russkamp, F. Pache, F.S. Zetoune, J.V. Sarma, and P.A. Ward MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway FASEB J 25 2011 4222 4232
15. N. Takahashi, I. Vanlaere, R. de Rycke, A. Cauwels, L.A. Joosten, E. Lubberts, W.B. van den Berg, and C. Libert IL-17 produced by Paneth cells drives TNF-induced shock J Exp Med 205 2008 1755 1761
16. D.J. Cua, and C.M. Tato Innate IL-17-producing cells: the sentinels of the immune system Nat Rev Immunol 10 2010 479 489
17. A.E. Price, R.L. Reinhardt, H.E. Liang, and R.M. Locksley Marking and quantifying IL-17A-producing cells in vivo PLoS One 7 2012 e39750
18. D.R. Chung, D.L. Kasper, R.J. Panzo, T. Chitnis, M.J. Grusby, M.H. Sayegh, and A.O. Tzianabos CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism J Immunology 170 2003 1958 1963
19. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, R. Jaeschke, K. Reinhart, D.C. Angus, C. Brun-Buisson, R. Beale, T. Calandra, J.F. Dhainaut, H. Gerlach, M. Harvey, J.J. Marini, J. Marshall, M. Ranieri, G. Ramsay, J. Sevransky, B.T. Thompson, S. Townsend, J.S. Vender, J.L. Zimmerman, and J.L. Vincent Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
20. M. Bosmann, N.F. Russkamp, V.R. Patel, F.S. Zetoune, J.V. Sarma, and P.A. Ward The outcome of polymicrobial sepsis is independent of T and B cells Shock 36 2011 396 401
21. M. Bosmann, M.D. Haggadone, M.R. Hemmila, F.S. Zetoune, J.V. Sarma, and P.A. Ward Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced. Production of IL-27(p28) from macrophages J Immunol 188 2012 5086 5093
22. M.P. Sambhi, M.H. Weil, V.N. Udhoji, and H. Shubin Adrenocorticoids in the management of shock Int Anesthesiol Clin 2 1964 421 433
23. R. Bertini, M. Bianchi, and P. Ghezzi Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor J Exp Med 167 1988 1708 1712
24. R.S. Abernathy, F. Halberg, and W.W. Spink Studies on the mechanism of chlorpromazine protection against Brucella endotoxin in mice J Lab Clin Med 49 1957 708 715
25. A. Freitas, J.C. Alves-Filho, T. Victoni, T. Secher, H.P. Lemos, F. Sonego, F.Q. Cunha, and B. Ryffel IL-17 receptor signaling is required to control polymicrobial sepsis J Immunol 182 2009 7846 7854
26. D. Mesotten, I. Vanhorebeek, and G. Van den Berghe The altered adrenal axis and treatment with glucocorticoids during critical illness Nat Clin Pract Endocrinol Metab 4 2008 496 505
27. D.Y. Leung, and J.W. Bloom Update on glucocorticoid action and resistance J Allergy Clin Immunol 111 2003 3 22 quiz, 23
28. M. Ziolkowska, A. Koc, G. Luszczykiewicz, K. Ksiezopolska-Pietrzak, E. Klimczak, H. Chwalinska-Sadowska, and W. Maslinski High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism J Immunol 164 2000 2832 2838
29. T. Shalom-Barak, J. Quach, and M. Lotz Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB J Biol Chem 273 1998 27467 27473
30. M. Laan, Z.H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, D.C. Gruenert, B.E. Skoogh, and A. Linden Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways J Immunol 162 1999 2347 2352
31. B. de Paz, C. Prado, M. Alperi-Lopez, F.J. Ballina-Garcia, J. Rodriguez-Carrio, P. Lopez, and A. Suarez Effects of glucocorticoid treatment on CD25-FOXP3+ population and cytokine-producing cells in rheumatoid arthritis Rheumatology (Oxford) 51 2012 1198 1207
32. L. McKinley, J.F. Alcorn, A. Peterson, R.B. Dupont, S. Kapadia, A. Logar, A. Henry, C.G. Irvin, J.D. Piganelli, A. Ray, and J.K. Kolls TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice J Immunol 181 2008 4089 4097
33. K.J. Tracey Reflex control of immunity Nat Rev Immunol 9 2009 418 428
34. J. Bergquist, A. Tarkowski, R. Ekman, and A. Ewing Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop Proc Natl Acad Sci U S A 91 1994 12912 12916
35. B. Saha, A.C. Mondal, J. Majumder, S. Basu, and P.S. Dasgupta Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism Neuroimmunomodulation 9 2001 23 33
36. M. Bosmann, J.J. Grailer, K. Zhu, M.A. Matthay, J.V. Sarma, F.S. Zetoune, and P.A. Ward Anti-inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury FASEB J 26 2012 2137 2144
37. A. Severn, N.T. Rapson, C.A. Hunter, and F.Y. Liew Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists J Immunol 148 1992 3441 3445
38. T. van der Poll, S.M. Coyle, K. Barbosa, C.C. Braxton, and S.F. Lowry Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia J Clin Invest 97 1996 713 719
39. T. van der Poll, J. Jansen, E. Endert, H.P. Sauerwein, and S.J. van Deventer Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood Infect Immun 62 1994 2046 2050
40. M.A. Flierl, D. Rittirsch, M. Huber-Lang, J.V. Sarma, and P.A. Ward Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box? Mol Med 14 2008 195 204
41. M.A. Flierl, D. Rittirsch, B.A. Nadeau, A.J. Chen, J.V. Sarma, F.S. Zetoune, S.R. McGuire, R.P. List, D.E. Day, L.M. Hoesel, H. Gao, N. Van Rooijen, M.S. Huber-Lang, R.R. Neubig, and P.A. Ward Phagocyte-derived catecholamines enhance acute inflammatory injury Nature 449 2007 721 725
42. M.A. Flierl, D. Rittirsch, B.A. Nadeau, J.V. Sarma, D.E. Day, A.B. Lentsch, M.S. Huber-Lang, and P.A. Ward Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response PLoS One 4 2009 e4414